These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22639401)

  • 1. Sirolimus: more cause for alarm?
    Agarwal PD; Lucey MR
    Liver Transpl; 2012 Sep; 18(9):1003-4. PubMed ID: 22639401
    [No Abstract]   [Full Text] [Related]  

  • 2. End of the line for sirolimus in liver transplant recipients with hepatitis C virus?
    De Simone P; Saliba F; Fischer L
    Liver Transpl; 2013 Feb; 19(2):236-7. PubMed ID: 23225519
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
    Watt KD; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle.
    Levitsky J; Feng S
    Am J Transplant; 2014 Feb; 14(2):249-50. PubMed ID: 24620373
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.
    Mueller AR; Platz K; Willimski C; Berg T; Steinmüller T; Neumann U; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1347-9. PubMed ID: 11267321
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM; Lohmann R; Guckelberger O; Müller AR; Raakow R; Nüssler NC; Klupp J; Pfitzmann R; Jonas S; Settmacher U; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
    Asrani SK; Wiesner RH; Trotter JF; Klintmalm G; Katz E; Maller E; Roberts J; Kneteman N; Teperman L; Fung JJ; Millis JM
    Am J Transplant; 2014 Feb; 14(2):356-66. PubMed ID: 24456026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 10. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results.
    Pridöhl O; Heinemann K; Hartwig T; Witzigmann H; Lamesch P; Fangmann J; Berr F; Hauss J; Kohlhaw K
    Transplant Proc; 2001; 33(7-8):3229-31. PubMed ID: 11750384
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus in liver transplantation.
    Trotter JF
    Transplant Proc; 2003 May; 35(3 Suppl):193S-200S. PubMed ID: 12742496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
    Samuel D; Bismuth H; Boillot O; Ducerf C; Baulieux J; Gugenheim J; Baldini E; Launois B; Messner M; Wolf P; Ellero E; Domergue J; Pageaux J; Cherqui D; Duvoux C; Durand F; Belghiti J; Calmus Y; Massault PP; Neau-Cransac M; Saric J; LeTreut Y; Campan P
    Transplant Proc; 1998 Jun; 30(4):1394-6. PubMed ID: 9636563
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
    Trotter JF; Wachs M; Bak T; Trouillot T; Stolpman N; Everson GT; Kam I
    Liver Transpl; 2001 Apr; 7(4):343-51. PubMed ID: 11303295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group.
    Transplant Proc; 1994 Dec; 26(6):3260-3. PubMed ID: 7527960
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation.
    Lauro A; Dazzi A; Ercolani G; Zanfi C; Golfieri L; Amaduzzi A; Cucchetti A; La Barba G; Grazi GL; D'Errico A; Vivarelli M; Cescon M; Varotti G; Del Gaudio M; Ravaioli M; Di Simone M; Faenza S; Pironi L; Pinna AD
    Transplant Proc; 2007 Jun; 39(5):1629-31. PubMed ID: 17580204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.